Funding for this research was provided by:
JSPS KAKENHI (JP22K17513)
Article History
Received: 23 May 2024
Accepted: 20 October 2024
First Online: 28 October 2024
Declarations
:
: The research ethics committee of Osaka Aoyama University approved the study on June 9, 2022 (No.0406). Written informed consent was obtained from all participants.
: Participants were informed in writing that the data would be processed in a manner that individual information could not be identified, and the data would be published in an article or presented at a conference. Their consent was obtained in writing.
: YK received research grants and honoraria from Takeda Pharmaceutical Company, Ltd. NS received research grants and honoraria for lectures from Takeda Pharmaceutical Company, Ltd. NH declares no conflict of interest.